New

Cardiac Marker Testing Market

2021

Cardiac Marker Testing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Reagents and Kits, Instruments); Biomarker Type (Troponin I and T, CK-MB, BNP, Myoglobin, Hs-CRP, Other Biomarkers); Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, Ischemia); End User (Laboratory Testing, Point-Of-Care-Testing, Others) and Geography

| Report Code: TIPRE00022451 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Cardiac Marker Testing Market 2028 By Product Type, Biomarker Type, Application, End User and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Cardiac markers involve enzymes, hormones, and proteins of various forms and are used in the patients for diagnosis and risk stratification regarding chest pain and presumed acute coronary syndrome. They identify the blood level and heart functioning. These substances are released into the blood at the time when the heart is stressed or damaged, and look out for any problems such as coronary syndrome and blockage in blood flow. The measurement of these markers helps to diagnose different heart syndromes, such as acute coronary syndrome and cardiac ischemia. The cardiac marker testing provides great specificity and can help in the identification of the conditions in the early stages of presentation like troponins; they are expected to be the fastest-growing segment in the whole cardiology market.

MARKET SCOPE

The "Global Cardiac Marker Testing Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the cardiac marker testing market with detailed market segmentation by product type, biomarker type, application, end user, and geography. The report provides key statistics on the market status of the leading cardiac marker testing market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •  Based on product type, the global cardiac marker testing market is segmented into reagents and kits and instruments.
  •  On the basis of biomarker type, the market is bifurcated into troponin I and T, CK-MB, BNP, myoglobin, hs-CRP and other biomarkers.
  •  On the basis of application, the market is bifurcated into myocardial infarction, congestive heart failure, acute coronary syndrome, atherosclerosis and ischemia.
  •  On the basis of end-users, the market is bifurcated into laboratory testing, point-of-care-testing and others.

MARKET DYNAMICS
Drivers

  •  The rising prevalence of cardiovascular diseases and increasing geriatric population drive the global cardiac marker testing market.
  •  Stimulating the ongoing clinical trials to identify novel cardiac markers and increased research and development activities in cardiac markers boosts the market growth.
  •  The growing investment from public and private organizations on cardiac biomarkers fuels the market growth.
  •  Increased healthcare expenditure and modernization of healthcare infrastructure by a larger population base propel the growth of the market.

Restraints

  •  Factors like technical problems regarding sample collection and storage.
  •  Issues related to regulatory and reimbursement systems.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The cardiac marker testing market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the cardiac marker testing market in these regions.

IMPACT OF COVID-19 ON CARDIAC MARKER TESTING MARKET

COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The shutdown of various plants and factories has affected the global supply chains and impacted the overall global market. The cardiac marker testing market faced a period of negative growth, which can be attributed to factors such as massive footfall in the number of patients visiting hospitals with cardiovascular conditions and those diagnosed with myocardial infarction. As strict guidelines were imposed in all areas of cardiology service hence, significant reductions can be seen in all areas, including outpatient clinics, investigations, procedures, and cardiology community services. But the increase in patient pool and relaxation in lockdown will result in the sustainable growth of the market.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the cardiac marker testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from cardiac marker testing market are anticipated to have lucrative growth opportunities in the future with the rising demand for cardiac marker testing in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the cardiac marker testing market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  Roche Diagnostics Ltd
  •  Abbott Laboratories
  •  Siemens Healthineers AG
  •  Danaher Corporation
  •  Ortho Clinical Diagnostics
  •  Randox laboratories Ltd.
  •  bioMérieux SA
  •  LSI Medience Corporation
  •  DiaSorin S.p.A.
  •  Bio-Rad Laboratories, Inc.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Cardiac Marker Testing Market - By Product Type
1.3.2 Cardiac Marker Testing Market - By Biomarker Type
1.3.3 Cardiac Marker Testing Market - By Application
1.3.4 Cardiac Marker Testing Market - By End User
1.3.5 Cardiac Marker Testing Market - By Region
1.3.5.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. CARDIAC MARKER TESTING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. CARDIAC MARKER TESTING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. CARDIAC MARKER TESTING MARKET - GLOBAL MARKET ANALYSIS
6.1. CARDIAC MARKER TESTING - GLOBAL MARKET OVERVIEW
6.2. CARDIAC MARKER TESTING - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. CARDIAC MARKER TESTING MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. REAGENTS AND KITS
7.3.1. Overview
7.3.2. Reagents and Kits Market Forecast and Analysis
7.4. INSTRUMENTS
7.4.1. Overview
7.4.2. Instruments Market Forecast and Analysis
7.4.3. Chemiluminescence Market
7.4.3.1. Overview
7.4.3.2. Chemiluminescence Market Forecast and Analysis
7.4.4. Immunofluorescence Market
7.4.4.1. Overview
7.4.4.2. Immunofluorescence Market Forecast and Analysis
7.4.5. ELISA Market
7.4.5.1. Overview
7.4.5.2. ELISA Market Forecast and Analysis
7.4.6. Immunochromatography Market
7.4.6.1. Overview
7.4.6.2. Immunochromatography Market Forecast and Analysis
8. CARDIAC MARKER TESTING MARKET - REVENUE AND FORECASTS TO 2028 - BIOMARKER TYPE
8.1. OVERVIEW
8.2. BIOMARKER TYPE MARKET FORECASTS AND ANALYSIS
8.3. TROPONIN I AND T
8.3.1. Overview
8.3.2. Troponin I and T Market Forecast and Analysis
8.4. CK-MB
8.4.1. Overview
8.4.2. CK-MB Market Forecast and Analysis
8.5. BNP
8.5.1. Overview
8.5.2. BNP Market Forecast and Analysis
8.6. MYOGLOBIN
8.6.1. Overview
8.6.2. Myoglobin Market Forecast and Analysis
8.7. HS-CRP
8.7.1. Overview
8.7.2. Hs-CRP Market Forecast and Analysis
8.8. OTHER BIOMARKERS
8.8.1. Overview
8.8.2. Other Biomarkers Market Forecast and Analysis
9. CARDIAC MARKER TESTING MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. MYOCARDIAL INFARCTION
9.3.1. Overview
9.3.2. Myocardial Infarction Market Forecast and Analysis
9.4. CONGESTIVE HEART FAILURE
9.4.1. Overview
9.4.2. Congestive Heart Failure Market Forecast and Analysis
9.5. ACUTE CORONARY SYNDROME
9.5.1. Overview
9.5.2. Acute Coronary Syndrome Market Forecast and Analysis
9.6. ATHEROSCLEROSIS
9.6.1. Overview
9.6.2. Atherosclerosis Market Forecast and Analysis
9.7. ISCHEMIA
9.7.1. Overview
9.7.2. Ischemia Market Forecast and Analysis
10. CARDIAC MARKER TESTING MARKET - REVENUE AND FORECASTS TO 2028 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. LABORATORY TESTING
10.3.1. Overview
10.3.2. Laboratory Testing Market Forecast and Analysis
10.4. POINT-OF-CARE-TESTING
10.4.1. Overview
10.4.2. Point-Of-Care-Testing Market Forecast and Analysis
10.5. OTHERS
10.5.1. Overview
10.5.2. Others Market Forecast and Analysis

11. CARDIAC MARKER TESTING MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Cardiac Marker Testing Market Overview
11.1.2 North America Cardiac Marker Testing Market Forecasts and Analysis
11.1.3 North America Cardiac Marker Testing Market Forecasts and Analysis - By Product Type
11.1.4 North America Cardiac Marker Testing Market Forecasts and Analysis - By Biomarker Type
11.1.5 North America Cardiac Marker Testing Market Forecasts and Analysis - By Application
11.1.6 North America Cardiac Marker Testing Market Forecasts and Analysis - By End User
11.1.7 North America Cardiac Marker Testing Market Forecasts and Analysis - By Countries
11.1.7.1 Canada Cardiac Marker Testing Market
11.1.7.1.1 Canada Cardiac Marker Testing Market by Product Type
11.1.7.1.2 Canada Cardiac Marker Testing Market by Biomarker Type
11.1.7.1.3 Canada Cardiac Marker Testing Market by Application
11.1.7.1.4 Canada Cardiac Marker Testing Market by End User
11.1.7.2 Mexico Cardiac Marker Testing Market
11.1.7.2.1 Mexico Cardiac Marker Testing Market by Product Type
11.1.7.2.2 Mexico Cardiac Marker Testing Market by Biomarker Type
11.1.7.2.3 Mexico Cardiac Marker Testing Market by Application
11.1.7.2.4 Mexico Cardiac Marker Testing Market by End User
11.1.7.3 US Cardiac Marker Testing Market
11.1.7.3.1 US Cardiac Marker Testing Market by Product Type
11.1.7.3.2 US Cardiac Marker Testing Market by Biomarker Type
11.1.7.3.3 US Cardiac Marker Testing Market by Application
11.1.7.3.4 US Cardiac Marker Testing Market by End User
11.2. EUROPE
11.2.1 Europe Cardiac Marker Testing Market Overview
11.2.2 Europe Cardiac Marker Testing Market Forecasts and Analysis
11.2.3 Europe Cardiac Marker Testing Market Forecasts and Analysis - By Product Type
11.2.4 Europe Cardiac Marker Testing Market Forecasts and Analysis - By Biomarker Type
11.2.5 Europe Cardiac Marker Testing Market Forecasts and Analysis - By Application
11.2.6 Europe Cardiac Marker Testing Market Forecasts and Analysis - By End User
11.2.7 Europe Cardiac Marker Testing Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Cardiac Marker Testing Market
11.2.7.1.1 Germany Cardiac Marker Testing Market by Product Type
11.2.7.1.2 Germany Cardiac Marker Testing Market by Biomarker Type
11.2.7.1.3 Germany Cardiac Marker Testing Market by Application
11.2.7.1.4 Germany Cardiac Marker Testing Market by End User
11.2.7.2 France Cardiac Marker Testing Market
11.2.7.2.1 France Cardiac Marker Testing Market by Product Type
11.2.7.2.2 France Cardiac Marker Testing Market by Biomarker Type
11.2.7.2.3 France Cardiac Marker Testing Market by Application
11.2.7.2.4 France Cardiac Marker Testing Market by End User
11.2.7.3 Italy Cardiac Marker Testing Market
11.2.7.3.1 Italy Cardiac Marker Testing Market by Product Type
11.2.7.3.2 Italy Cardiac Marker Testing Market by Biomarker Type
11.2.7.3.3 Italy Cardiac Marker Testing Market by Application
11.2.7.3.4 Italy Cardiac Marker Testing Market by End User
11.2.7.4 Spain Cardiac Marker Testing Market
11.2.7.4.1 Spain Cardiac Marker Testing Market by Product Type
11.2.7.4.2 Spain Cardiac Marker Testing Market by Biomarker Type
11.2.7.4.3 Spain Cardiac Marker Testing Market by Application
11.2.7.4.4 Spain Cardiac Marker Testing Market by End User
11.2.7.5 United Kingdom Cardiac Marker Testing Market
11.2.7.5.1 United Kingdom Cardiac Marker Testing Market by Product Type
11.2.7.5.2 United Kingdom Cardiac Marker Testing Market by Biomarker Type
11.2.7.5.3 United Kingdom Cardiac Marker Testing Market by Application
11.2.7.5.4 United Kingdom Cardiac Marker Testing Market by End User
11.2.7.6 Rest of Europe Cardiac Marker Testing Market
11.2.7.6.1 Rest of Europe Cardiac Marker Testing Market by Product Type
11.2.7.6.2 Rest of Europe Cardiac Marker Testing Market by Biomarker Type
11.2.7.6.3 Rest of Europe Cardiac Marker Testing Market by Application
11.2.7.6.4 Rest of Europe Cardiac Marker Testing Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Cardiac Marker Testing Market Overview
11.3.2 Asia-Pacific Cardiac Marker Testing Market Forecasts and Analysis
11.3.3 Asia-Pacific Cardiac Marker Testing Market Forecasts and Analysis - By Product Type
11.3.4 Asia-Pacific Cardiac Marker Testing Market Forecasts and Analysis - By Biomarker Type
11.3.5 Asia-Pacific Cardiac Marker Testing Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Cardiac Marker Testing Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Cardiac Marker Testing Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Cardiac Marker Testing Market
11.3.7.1.1 Australia Cardiac Marker Testing Market by Product Type
11.3.7.1.2 Australia Cardiac Marker Testing Market by Biomarker Type
11.3.7.1.3 Australia Cardiac Marker Testing Market by Application
11.3.7.1.4 Australia Cardiac Marker Testing Market by End User
11.3.7.2 China Cardiac Marker Testing Market
11.3.7.2.1 China Cardiac Marker Testing Market by Product Type
11.3.7.2.2 China Cardiac Marker Testing Market by Biomarker Type
11.3.7.2.3 China Cardiac Marker Testing Market by Application
11.3.7.2.4 China Cardiac Marker Testing Market by End User
11.3.7.3 India Cardiac Marker Testing Market
11.3.7.3.1 India Cardiac Marker Testing Market by Product Type
11.3.7.3.2 India Cardiac Marker Testing Market by Biomarker Type
11.3.7.3.3 India Cardiac Marker Testing Market by Application
11.3.7.3.4 India Cardiac Marker Testing Market by End User
11.3.7.4 Japan Cardiac Marker Testing Market
11.3.7.4.1 Japan Cardiac Marker Testing Market by Product Type
11.3.7.4.2 Japan Cardiac Marker Testing Market by Biomarker Type
11.3.7.4.3 Japan Cardiac Marker Testing Market by Application
11.3.7.4.4 Japan Cardiac Marker Testing Market by End User
11.3.7.5 South Korea Cardiac Marker Testing Market
11.3.7.5.1 South Korea Cardiac Marker Testing Market by Product Type
11.3.7.5.2 South Korea Cardiac Marker Testing Market by Biomarker Type
11.3.7.5.3 South Korea Cardiac Marker Testing Market by Application
11.3.7.5.4 South Korea Cardiac Marker Testing Market by End User
11.3.7.6 Rest of Asia-Pacific Cardiac Marker Testing Market
11.3.7.6.1 Rest of Asia-Pacific Cardiac Marker Testing Market by Product Type
11.3.7.6.2 Rest of Asia-Pacific Cardiac Marker Testing Market by Biomarker Type
11.3.7.6.3 Rest of Asia-Pacific Cardiac Marker Testing Market by Application
11.3.7.6.4 Rest of Asia-Pacific Cardiac Marker Testing Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Cardiac Marker Testing Market Overview
11.4.2 Middle East and Africa Cardiac Marker Testing Market Forecasts and Analysis
11.4.3 Middle East and Africa Cardiac Marker Testing Market Forecasts and Analysis - By Product Type
11.4.4 Middle East and Africa Cardiac Marker Testing Market Forecasts and Analysis - By Biomarker Type
11.4.5 Middle East and Africa Cardiac Marker Testing Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Cardiac Marker Testing Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Cardiac Marker Testing Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Cardiac Marker Testing Market
11.4.7.1.1 South Africa Cardiac Marker Testing Market by Product Type
11.4.7.1.2 South Africa Cardiac Marker Testing Market by Biomarker Type
11.4.7.1.3 South Africa Cardiac Marker Testing Market by Application
11.4.7.1.4 South Africa Cardiac Marker Testing Market by End User
11.4.7.2 Saudi Arabia Cardiac Marker Testing Market
11.4.7.2.1 Saudi Arabia Cardiac Marker Testing Market by Product Type
11.4.7.2.2 Saudi Arabia Cardiac Marker Testing Market by Biomarker Type
11.4.7.2.3 Saudi Arabia Cardiac Marker Testing Market by Application
11.4.7.2.4 Saudi Arabia Cardiac Marker Testing Market by End User
11.4.7.3 U.A.E Cardiac Marker Testing Market
11.4.7.3.1 U.A.E Cardiac Marker Testing Market by Product Type
11.4.7.3.2 U.A.E Cardiac Marker Testing Market by Biomarker Type
11.4.7.3.3 U.A.E Cardiac Marker Testing Market by Application
11.4.7.3.4 U.A.E Cardiac Marker Testing Market by End User
11.4.7.4 Rest of Middle East and Africa Cardiac Marker Testing Market
11.4.7.4.1 Rest of Middle East and Africa Cardiac Marker Testing Market by Product Type
11.4.7.4.2 Rest of Middle East and Africa Cardiac Marker Testing Market by Biomarker Type
11.4.7.4.3 Rest of Middle East and Africa Cardiac Marker Testing Market by Application
11.4.7.4.4 Rest of Middle East and Africa Cardiac Marker Testing Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Cardiac Marker Testing Market Overview
11.5.2 South and Central America Cardiac Marker Testing Market Forecasts and Analysis
11.5.3 South and Central America Cardiac Marker Testing Market Forecasts and Analysis - By Product Type
11.5.4 South and Central America Cardiac Marker Testing Market Forecasts and Analysis - By Biomarker Type
11.5.5 South and Central America Cardiac Marker Testing Market Forecasts and Analysis - By Application
11.5.6 South and Central America Cardiac Marker Testing Market Forecasts and Analysis - By End User
11.5.7 South and Central America Cardiac Marker Testing Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Cardiac Marker Testing Market
11.5.7.1.1 Brazil Cardiac Marker Testing Market by Product Type
11.5.7.1.2 Brazil Cardiac Marker Testing Market by Biomarker Type
11.5.7.1.3 Brazil Cardiac Marker Testing Market by Application
11.5.7.1.4 Brazil Cardiac Marker Testing Market by End User
11.5.7.2 Argentina Cardiac Marker Testing Market
11.5.7.2.1 Argentina Cardiac Marker Testing Market by Product Type
11.5.7.2.2 Argentina Cardiac Marker Testing Market by Biomarker Type
11.5.7.2.3 Argentina Cardiac Marker Testing Market by Application
11.5.7.2.4 Argentina Cardiac Marker Testing Market by End User
11.5.7.3 Rest of South and Central America Cardiac Marker Testing Market
11.5.7.3.1 Rest of South and Central America Cardiac Marker Testing Market by Product Type
11.5.7.3.2 Rest of South and Central America Cardiac Marker Testing Market by Biomarker Type
11.5.7.3.3 Rest of South and Central America Cardiac Marker Testing Market by Application
11.5.7.3.4 Rest of South and Central America Cardiac Marker Testing Market by End User

12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

13. CARDIAC MARKER TESTING MARKET, KEY COMPANY PROFILES
13.1. ROCHE DIAGNOSTICS LTD
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ABBOTT LABORATORIES
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. SIEMENS HEALTHINEERS AG
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. DANAHER CORPORATION
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. ORTHO CLINICAL DIAGNOSTICS
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. RANDOX LABORATORIES LTD.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. BIOMéRIEUX SA
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. LSI MEDIENCE CORPORATION
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. DIASORIN S.P.A.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. BIO-RAD LABORATORIES, INC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments

14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Roche Diagnostics Ltd
2. Abbott Laboratories
3. Siemens Healthineers AG
4. Danaher Corporation
5. Ortho Clinical Diagnostics
6. Randox laboratories Ltd.
7. bioMérieux SA
8. LSI Medience Corporation
9. DiaSorin S.p.A.
10. Bio-Rad Laboratories, Inc.
TIPRE00022451
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.